Castellví Suaña J M, Perelló Juan A, Cervantes Arnau X, Guardiola Capón J, Baliellas Comellas C, Xiol Quingles X
Servicio de Aparato Digestivo, Ciutat Sanitària Universitària de Bellvitge, L'Hospitalet, Barcelona.
Rev Esp Enferm Dig. 1994 Dec;86(6):908-11.
Autoimmune hemolytic anemia is a rare complication of ulcerative colitis. A retrospective review of the cases of ulcerative colitis treated at our hospital between January 1984 and August 1993 showed that, among 210 patients, three presented autoimmune hemolytic anemia with a positive direct Coomb's test. They were two men and one woman suffering from a moderately active ulcerative colitis that affected the left colon. The hemolysis was diagnosed before the onset of colitis in two cases and after it in the other. In the only patient treated with sulphasalazine, this drug was stopped without improvement. All the patients were treated with steroids, with resolution of the anemia in one of them. Healing was achieved with splenectomy in the other two. Colectomy was not necessary in any case. After suppression of sulphasalazine and treatment with steroids, the next therapeutic option in patients with ulcerative colitis and autoimmune hemolytic anemia should be splenectomy, whereas colectomy should be only used with unresponsive patients, as well as with those affected by severe ulcerative colitis refractory to steroids. In patients presenting with ulcerative colitis and anemia, the possibility of autoimmune hemolytic anemia has to be considered since--in spite of being rare--it is responsive to proper treatment.
自身免疫性溶血性贫血是溃疡性结肠炎的一种罕见并发症。对我院1984年1月至1993年8月间收治的溃疡性结肠炎病例进行回顾性研究发现,在210例患者中,有3例出现直接抗人球蛋白试验阳性的自身免疫性溶血性贫血。他们是2名男性和1名女性,患有累及左半结肠的中度活动性溃疡性结肠炎。2例溶血在结肠炎发作前被诊断出来,另1例在结肠炎发作后被诊断出来。在唯一接受柳氮磺胺吡啶治疗的患者中,停用该药物后病情并无改善。所有患者均接受了类固醇治疗,其中1例贫血得到缓解。另外2例通过脾切除术治愈。所有病例均无需进行结肠切除术。在停用柳氮磺胺吡啶并接受类固醇治疗后,溃疡性结肠炎合并自身免疫性溶血性贫血患者的下一步治疗选择应是脾切除术,而结肠切除术仅应用于治疗无效的患者以及对类固醇治疗无效的重症溃疡性结肠炎患者。对于患有溃疡性结肠炎和贫血的患者,必须考虑自身免疫性溶血性贫血的可能性,因为尽管这种情况罕见,但它对适当的治疗有反应。